Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | Methanimidamide, hydrochloride (1:1) | HCID 10313058 | — |
| Reactant | 3-[3-(3,5-difluorophenyl)-2-(1,3-dihydrobenzimidazol-2-ylidene)-3-oxopropanoyl]benzenesulfonyl chloride | HCID 178520871 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 178513452 | HCID 178513452 | — |
Reaction Steps
60% Sodium hydride (809 mg) was added to a DMF (30 mL) solution of formamidine hydrochloride (1.92 g), followed by stirring at room temperature for 15 minutes. A DMF (10 mL) solution of 3-[3-(3,5-difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-3-oxopropanoyl]benzenesulfonyl chloride (hereinafter referred to as starting compound A, 1.13 g) was added, followed by stirring at room temperature for 1.5 hours. The reaction mixture was poured into an excess amount of aqueous ammonium chloride solution, followed by extraction with ethyl acetate. The organic layer was washed with water, concentrated under reduced pressure, purified by silica gel column chromatography (chloroform/methanol=10/1), and crystallized from diethyl ether/n-hexane to obtain 3-[3-(3,5-difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-3-oxopropanoyl]-N-(iminomethyl)benzenesulfonamide (81 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07960562B2 |
|---|
| Source dataset | uspto-grants-2011_06 |
|---|
| ORD ID | ord-2269d2a802044b7d868badbaf0a285a9 |
|---|
| Source note | uspto-grants-2011_06 |
|---|